Mitragynine pseudoindoxyl
| Clinical data | |
|---|---|
| Other names | Spiro(2H-indole-2,1'(5'H)-indolizine)-7'-acetic acid, 6'-ethyl-1,2',3,3',6',7',8',8'a-octahydro-4-methoxy-alpha-(methoxymethylene)-3-oxo-, methyl ester, (alphaE,1'S,6'S,7'S,8'as)- | 
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C23H30N2O5 | 
| Molar mass | 414.502 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
Mitragynine pseudoindoxyl is a rearrangement product of 7-hydroxymitragynine, an active metabolite of mitragynine.
Mitragynine pseudoindoxyl can be produced in the blood as a metabolite of 7-hydroxymitragynine.